Sonnet Biotherapeutics Holdings Inc (SONN) — Capital Reinvestment Ratio

Latest as of September 2018: 1.54x

Sonnet Biotherapeutics Holdings Inc (SONN) has a Capital Reinvestment Ratio of 1.54x as of September 2018, meaning it reinvests 2% of its operating cash flow ($670.16K) in capital expenditures ($1.03 Million). Check tangible equity quality of Sonnet Biotherapeutics Holdings Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.54x
Capex / Operating Cash Flow

Operating Cash Flow

$670.16K
USD

Capital Expenditures

$1.03 Million
USD

Data as of

Sep 2018
Most recent filing

Annual Capital Reinvestment Ratio for Sonnet Biotherapeutics Holdings Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Sonnet Biotherapeutics Holdings Inc from None to None. See Sonnet Biotherapeutics Holdings Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow